Like it or not, biologists have to deal increasingly in informatics as their experiments generate ever larger and more complex data sets. Few laboratories have the resources to develop their own ...

Genomatix Software GmbH today announced that it has achieved GeneChip-compatible TM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has ...

KFB - Center of Excellence for Fluorescent Bioanalysis integrates Genomatix GeneChip® Analysis-Pipeline into its product portfolio. Premium services offered for premium results Munich, Regensburg ...

SANTA CLARA, Calif. & SAN DIEGO--(BUSINESS WIRE)--Affymetrix Inc. (NASDAQ:AFFX) and Reveal Biosciences LLC, an advanced tissue technologies company, today announced a partnership agreement through ...

NEW YORK (CBS.MW) -- Affymetrix Inc. said Monday the U.S. Food and Drug Administration has approved its GeneChip system 3000Dx, an instrumentation system to analyze in vitro diagnostic microarrays.

Five to seven years ago, only a few biotech visionaries could foresee how much of the industry would involve not monoclonal antibodies, or even gene therapy, or anything involving test tubes at all.

SANTA CLARA, Calif. & PARIS--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ: AFFX) and ScreenCell, a privately-held company, today announced the signing of a worldwide distribution agreement for ScreenCell ...

Ron Davis and I were studying plant transcription factors in 1990, but progress was slow and arduous because the gene expression tools were so primitive. We conceived of the DNA microarray in 1993 to ...